Longaeva Partners »

Xenon Pharmaceuticals shares owned by Longaeva Partners

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $363k 6.3k 58.15

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Xenon Pharmaceuticals

FMR
BlackRock
venBio Select Advisor
Wellington Management Company
Driehaus Capital Management
Henderson Group
Citadel Advisors
Capital Research and Management Company - Division 3
Polar Capital Holdings
Deerfield Management Company
Holocene Advisors
State Street Corporation
Alliancebernstein
Westfield Capital Management Company
Braidwell

View all funds holding Xenon Pharmaceuticals